Papadaki C, Mavroudis D, Trypaki M, Koutsopoulos A, Stathopoulos E, Hatzidaki D, Tsakalaki E, Georgoulias V, Souglakos J (June 2009). "Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxel-gemcitabine regimen". Clin. Cancer Res. 15 (11): 3827–33. doi:10.1158/1078-0432.CCR-08-3027. PMID19435835.
Bi J, Bai Z, Ma X, Song J, Guo Y, Zhao J, Yi X, Han S, Zhang Z (February 2014). "Txr1: an important factor in oxaliplatin resistance in gastric cancer". Med. Oncol. 31 (2): 807. doi:10.1007/s12032-013-0807-1. PMID24362794.